DOTA-XYIMSR-01, CAS [[2051527-54-7]] Preis auf Anfrage

Artikelnummer: BYT-ORB3028605
Artikelname: DOTA-XYIMSR-01, CAS [[2051527-54-7]] Preis auf Anfrage
Artikelnummer: BYT-ORB3028605
Hersteller Artikelnummer: orb3028605
Alternativnummer: BYT-ORB3028605-10, BYT-ORB3028605-50
Hersteller: Biorbyt
Kategorie: Sonstiges
DOTA-XYIMSR-01 is a molecular probe targeting CAIX, capable of being labeled with 177Lu for the treatment and localization of malignant gliomas. The uptake of [177Lu]Lu-XYIMSR-01 in U87MG tumors is 6.19% injected dose per gram (% ID/g), with a tumor-to-muscle uptake ratio of 20.14. In an orthotopic glioma model, co-administration with temozolomide significantly enhances survival rates and inhibits tumor growth in mice. DOTA-XYIMSR-01 shows potential for research in the field of cancer treatment.
Molekulargewicht: 1461.57
CAS Nummer: [2051527-54-7]
Formel: C61H88N16O22S2
Target-Kategorie: Carbonic Anhydrase